Oct 01, 2020 / 11:15PM GMT
Operator
Hello, and welcome to the corporate update from Mesoblast. An announcement has been lodged with the ASX and also available on the home and investor pages at www.mesoblast.com. (Operator Instructions) As a reminder, this conference call is being recorded.
Before we begin, let me remind you that during today's conference, the company will be making forward-looking statements that represent the company's intentions, expectations or beliefs concerning the future events. These forward-looking statements are qualified by important factors set forth in today's announcement and the company's filings with the SEC, which could cause actual results to differ materially from those in such forward-looking statements. In addition, any forward-looking statements represent the company's views only as of the date of this webcast and should not be relied upon as representing the company's views of any subsequent date. The company specifically disclaims any obligations to update such statements.
With that, I would now like to turn the call
Mesoblast Ltd Announces FDA's Response Letter for Approval of Remestemcel-L for GvHD Call Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers